Navigation Links
Drug from Mediterranean weed kills tumor cells in mice
Date:7/9/2012

Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel -- undetected by normal cells -- through the bloodstream until activated by specific cancer proteins. The drug, made from a weedlike plant, has been shown to destroy cancers and their direct blood supplies, acting like a "molecular grenade," and sparing healthy blood vessels and tissues.

In laboratory studies, researchers said they found that a three-day course of the drug, called G202, reduced the size of human prostate tumors grown in mice by an average of 50 percent within 30 days. In a direct comparison, G202 outperformed the chemotherapy drug docetaxel, reducing seven of nine human prostate tumors in mice by more than 50 percent in 21 days. Docetaxel reduced one of eight human prostate tumors in mice by more than 50 percent in the same time period.

In a report June 27 in the journal Science Translational Medicine, the researchers also reported that G202 produced at least 50 percent regression in models of human breast cancer, kidney cancer and bladder cancer.

Based on these results, Johns Hopkins physicians have performed a phase I clinical trial to assess safety of the drug and have thus far treated 29 patients with advanced cancer. In addition to Johns Hopkins, the University of Wisconsin and the University of Texas-San Antonio are participating in the trial. A phase II trial to test the drug in patients with prostate cancer and liver cancer is planned.

The drug G202 is chemically derived from a weed called Thapsia garganica that grows naturally in the Mediterranean region. The plant makes a product, dubbed thapsigargin, that since the time of ancient Greece has been known to be toxic to animals. In Arab caravans, the plant was known as the "death carrot" because it would kill camels if they ate it, the researchers noted.

"Our goal was to try to re-engineer
'/>"/>

Contact: Vanessa Wasta
wasta@jhmi.edu
410-955-1287
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2

Related medicine news :

1. The Mediterranean diet is definitively linked to quality of life
2. Glucose deprivation activates feedback loop that kills cancer cells, UCLA study shows
3. Sleep apnea persisting into teens can impact life skills, study finds
4. Drug kills cancer cells by restoring faulty tumor suppressor
5. Grant awarded to help improve problem-solving skills for deaf and hard-of-hearing students
6. More Evidence Bilingualism Aids Thinking Skills
7. Parents poor math skills may lead to medication errors
8. Physicians mindfulness skills can improve care for patient and provider
9. Pediatric tumors traced to stem cells in developing brain​​
10. Skin contact breast tumor detection
11. Specialized MRI scans assess value of anti-cancer chemotherapy long before tumors shown to shrink
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... ... 29, 2015 , ... ProDrop Particles includes over 40 particle backdrops designed for ... unique footage that users can shrink and stretch in the Final Cut Pro X ... customize color, brightness, scale, speed, range, and flare attributes with intuitive controls found in ...
(Date:8/29/2015)... ... August 29, 2015 , ... Vascular Health Sciences announced ... Arterosil and Arterosil HP, and that all claims and counterclaims have been irrevocably ... LLC (VHS) in the United States District Court for the Southern District of ...
(Date:8/28/2015)... ... August 28, 2015 , ... Approximately ... the Zoo to celebrate children helping children, a thank you to the many ... Ohio have contributed to the United Methodist initiative to end malaria deaths. , ...
(Date:8/28/2015)... ... August 28, 2015 , ... For Dallas, the time is ... with their subsidiary USPI Tenet Health. , The American Heart Association hosts their well-known ... stroke. They believe that together, a difference can be made. Walkers can participate in ...
(Date:8/28/2015)... Manistee, Michigan (PRWEB) , ... August 28, 2015 , ... ... in Western Michigan, joined as sponsor of the “Music With A Mission” benefit concert ... purpose behind the event was to raise money to support music education programs in ...
Breaking Medicine News(10 mins):Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2
... Feb. 21 AK Steel (NYSE:,AKS) said today that ... agreement between AK Steel and a group of retirees ... from the company,s,initiatives in 2006 to reduce its health ... settlement agreement, which established a Voluntary Employees,Beneficiary Association (VEBA) ...
... Feb. 21 The needs of,pregnant women, babies and toddlers ... Healthy Start of Southwest Florida has received a $6,000,grant from ... how we,can best help the 18,000 clients we serve each ... in the last five,years. The population has increased and the ...
... new electron microscope recently installed in Cornell,s Duffield Hall ... images that uniquely identify individual atoms in a crystal ... And in living color. , "The current generation of ... and white cameras where different atoms appear as different ...
... whose discoveries have led to fundamental advances in the ... two prestigious international prizes offered by the Kirk A. ... for Cancer Research (AACR). , The Kirk A. ... Landon-AACR Prize for Translational Cancer Research are among the ...
... Sons, Inc. (NYSE: JWa), (NYSE: JWb), today announced that it ... its worldwide operations that were formerly part of Blackwell Publishing, ... addition to offsetting the carbon footprint of 10 offices around ... that result from the global product shipments from this part ...
... of adverse side effects , , THURSDAY, Feb. ... one nonsteroidal anti-inflammatory drug (NSAID) may have poorer health-related ... which are available in both prescription and over-the-counter (OTC) ... drugs are widely available, and patients may take both ...
Cached Medicine News:Health News:U.S. Court Approves AK Steel's VEBA Health Care Settlement With Middletown Works Retirees 2Health News:Healthy Start of Southwest Florida Receives Grant From March of Dimes to Assess Needs of Pregnant Women and Babies 2Health News:By color-coding atoms, new Cornell electron microscope promises big advance in materials analysis 2Health News:By color-coding atoms, new Cornell electron microscope promises big advance in materials analysis 3Health News:AACR's Seventh Annual Landon Awards 2Health News:AACR's Seventh Annual Landon Awards 3Health News:AACR's Seventh Annual Landon Awards 4Health News:AACR's Seventh Annual Landon Awards 5Health News:Taking Multiple Pain Relievers May Cause Complications 2
(Date:8/28/2015)... August 28, 2015 The report "Eubiotics Market by ... Poultry, Ruminant, and Aquaculture), & by Region ( North ... Asia-Pacific , and Rest of the World) - Global ... market for Eubiotics was valued at USD 4.62 Billion in ... 2020, at a CAGR of 7.4% from 2015 to 2020. ...
(Date:8/28/2015)... , August 28, 2015 The ... reach USD 49.12 billion by 2020, growing at a ... a new report by Grand View Research, Inc. Monitoring ... of 49.7% from 2014 to 2020.      ... population along with rising incidences of chronic diseases such ...
(Date:8/27/2015)... 27, 2015 DURECT Corporation (Nasdaq: DRRX ... at three upcoming healthcare conferences.  , ... present at the Rodman & Renshaw Investment Conference on ... conference is being held at the St. Regis Hotel ... live audio webcast of the presentation will be available ...
Breaking Medicine Technology:Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5DURECT to Participate in Upcoming Healthcare Conferences 2
... Masimo (NASDAQ: MASI ... & Human Services (HHS) has added Critical Congenital Heart ... national newborn screening standard.  In addition, the largest UK ... online in the Lancet (appearing in the ...
... 23, 2011 Bayer HealthCare Pharmaceuticals today announced that ... the Phase III ALSYMPCA ( AL pharadin in ... The study met its primary endpoint by significantly improving ... castration-resistant prostate cancer (CRPC) and symptomatic bone metastases. All ...
Cached Medicine Technology:U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 2U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 3U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 4U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 5U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 6U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 7U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 8U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 9U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 10Positive Phase III Data on Bayer's Investigational Drug Radium-223 Chloride Show Significant Increase in Overall Survival 2Positive Phase III Data on Bayer's Investigational Drug Radium-223 Chloride Show Significant Increase in Overall Survival 3Positive Phase III Data on Bayer's Investigational Drug Radium-223 Chloride Show Significant Increase in Overall Survival 4
... anyone using the Farnsworth D15, L'Anthony desaturated test ... patients cannot avoid touching the color disks with ... Further, the disks are very easy to loose.,We ... in order to solve these problems. We have ...
... Farnsworth Dichotomous testing sets are designed ... The Farnsworth D15 test is used to ... Normal. The L'Anthony Desaturated test is much ... mild deficiency from Normal. Both of ...
... The NOW Strep A test is as easy ... minutes to results. Increase patient satisfaction with rapid ... can treat your patient immediately with the appropriate ... , ,Intended Use: ,The NOW® Strep A Test ...
12 mm single use, reloadable laparoscopic linear stapler with titanium staples....
Medicine Products: